Oral Presentations 8: Respiratory and Inflammation
Tracks
Track 8
| Tuesday, July 14, 2026 |
| 9:00 AM - 10:30 AM |
Speaker
Prof Ming-quan Guo
Ningbo Cixi Institute Of Biomedical Engineering
Multifunctional bioactive compounds from two traditional herbs against metabolic disorders
9:00 AM - 9:15 AMBiography
Prof. Guo is currently a full Professor at the University of Chinese Academy of Sciences, and the head of Natural Biomedical Materials Group at Ningbo Cixi Institute of Biomedical Engineering. He received his Ph. D. degree in Physical chemistry in 2003 from CAS. From 2004 to 2012, he continued his research on drug discovery and development successively at NIH, UC-LBNL and USC in USA. In 2013, he joined CAS as a full professor. By far, he has published over 140 SCI articles in a number of high impact journals such as Journal of Pharmaceutical Analysis, Food Chemistry, and Proteomics, etc; and has acted as PIs for over 30 natioanl or international scientific projects. He has also served as Guest Editor or Associate guest editor for 4 SCI journals, and as EBM for 6 SCI journals.He has been ranked among the Top 2% of scientists in the WORLD since 2022.
Dr Qingxu Ha
Shanghai Children's Medical Center Affiliated To Shanghai Jiao Tong University School Of Medicine
Modified Danggui-Buxue Decoction Alleviates Bleomycin-Induced Pulmonary Fibrosis by Regulating the HMGB1/TLR4 Pathway
9:15 AM - 9:30 AMBiography
Ha Qingxu (2000- present) is currently employed at Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, with a research focus on pulmonary fibrosis
Mr Hudson Taylor-Blair
University of Technology Sydney
Australian air pollution exposure triggers neutrophil-dominant, steroid‑refractory experimental asthma
9:30 AM - 9:45 AMBiography
Hudson Taylor-Blair is a first year PhD student at the University of Technology Sydney and the Woolcock Institute of Medical Research under the supervision of Distinguished Professor Brian Oliver, Dr Chantal Donovan and Dr Richard Kim. Hudson's research is exploring how environmental pollutants can cause, and exacerbate, respiratory diseases.
Ms Jessica Tolentino
University of Technology Sydney
CXCR3 antagonism via SCH546738 attenuates pathophysiological features of asthma and severe asthma
9:45 AM - 10:00 AMBiography
Jessica Tolentino is a second-year PhD candidate at the University of Technology Sydney under the supervision of Dr Chantal Donovan and Dr Richard Kim as part of the ImmunoPharmacology Research Group (IPRG). Her research focuses on asthma, with a primary focus on targeting the alpha-chemokine receptor, CXCR3, with a potent inhibitor to treat and manage asthma.
Mr Hoang Vu
University of Western Australia
Mr Yicheng Lin
School of Pharmacy;Fujian Medical University
Neonatal Fc Receptor/CXCR4 Bispecific Attenuates Immune-Complex Kidney Injury in Lupus
10:15 AM - 10:30 AMBiography
Yicheng Lin is a second-year Master's student in Pharmacy(Clinical Pharmacy track) at the School of Pharmacy, FujianMedical University. He received his Bachelor's degree in ClinicalPharmacy through a five-year program and is currently pursuinggraduate training in clinical pharmacy.
Session chair
Robert Newton
University of Calgary
Jessica Tolentino
University of Technology Sydney